Essential drugs for cancer therapy: A World Health Organization consultation
Open Access
- 1 April 1999
- journal article
- review article
- Published by Elsevier BV in Annals of Oncology
- Vol. 10 (4), 385-390
- https://doi.org/10.1023/a:1008367822016
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Gene Therapy in the developing worldGene Therapy, 1998
- 5-HT3 receptor antagonists: Differences and similaritiesEuropean Journal Of Cancer, 1997
- Paclitaxel and docetaxel in breast and ovarian cancerDrug and Therapeutics Bulletin, 1997
- Analysis of the cost-effectiveness of paclitaxel as alternative combination therapy for advanced ovarian cancer.Journal of Clinical Oncology, 1997
- OncoLink: A Cancer Information Resource for Gynecologic Oncologists and the Public on the InternetGynecologic Oncology, 1996
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Advances and Trends in Hormonal Therapy for Advanced Prostate CancerEuropean Urology, 1995
- Centralised treatment, entry to trials and survivalBritish Journal of Cancer, 1994
- Do treatment protocols improve end results? A study of survival of patients with multiple myeloma in Finland.BMJ, 1989
- Dose: A critical factor in cancer chemotherapyAmerican Journal Of Medicine, 1980